Eli Lilly and Company (LLY BE) stock market data APIs
€900.9481
-13.07(-1.5%)
as of December 15, 2025
Try our APIs with
free plan!
Eli Lilly and Company Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for LLY.BE.
Prev. Close
900.9481
Open
887.8759
High
901.2734
Low
882.0533
52 wk Range
537.5737-961
Market Cap
206 794 M
EPS
3.34
Dividends (Yield)
0.0146
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eli Lilly and Company data using free add-ons & libraries
Get Eli Lilly and Company Fundamental Data
Eli Lilly and Company Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-01
- EPS/Forecast: 3.03
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eli Lilly and Company News
New
Scotiabank Remains Bullish on Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the most profitable NYSE stocks to buy right now. In a report released on December 12, Scotiabank analyst Louise Chen reiterated a Buy rating on Eli Lilly an...
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Why Eli Lilly (LLY) Stock Is Trading Up Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the stock benefited as investors rotated capital out of the volatile technology se...
CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval
Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the EU approval of a higher do...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
